Yahoo Web Search

Search results

1. • 

     Regenerative medicine effort generates interest in Manchester growth

     New Hampshire Union Leader· 5 days ago

     One company in Manchester’s Millyard is working on a retinal patch to help cure macular degeneration...

2. • ReMDO Unveils Regulatory NavigatOR: A Guide throug | Newswise

     Newswise· 1 day ago

     The announcement was made at their annual Regenerative Manufacturing Innovation Consortium (RegMIC) meeting in Charlotte, North Carolina. The Regulatory...

3. • Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative ...

     FOX 23 News Albany· 20 hours ago

     The grant, a first for an autologous therapeutic for degenerative neurological conditions...

4. • DoD gives ARMI another $100M, much of it for workforce development

     New Hampshire Union Leader, Manchester via Yahoo Finance· 6 days ago

     May 9—MANCHESTER — Inventor Dean Kamen spilled the news about getting a $100 million federal grant he hopes will help make Manchester a major hub for regenerative

5. • Organogenesis Holdings Inc. Reports First Quarter 2024 Results:

     Guru Focus· 6 days ago

     On May 9, 2024, Organogenesis Holdings Inc (ORGO, Financial), a pioneer in regenerative medicine, announced its financial outcomes for the first quarter ...

6. • How is Regenerative Medicine Helping People Age Better? - LA Weekly

     LA Weekly· 2 days ago

     There are products, programs and advice to help counter the effects of the degenerative process in our body that is aging. We dread it so much but hardly ever

7. • Reclaim BioHealth: Regenerative Medicine for Structural Tissue Restoration

     Digital Journal· 6 days ago

     ...Rebuilding Structural Tissue Minneapolis, United States - May 10, 2024 / Reclaim BioHealth / Reclaim BioHealth Unveils the Power of Regenerative Medicine for Structural Tissue Restoration Minneapolis, MN Reclaim BioHealth, a trailblazer in regenerative medical technologies, is excited to...

8. • 

     Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results By Investing.com

     Investing.com· 6 days ago

     In a recent earnings call, Lineage Cell Therapeutics (NYSE:LCTX), a biotechnology company...

9. • 

     ProKidney on track to resume manufacturing in a few months, discloses exec compensation - Triad...

     The Business Journals· 2 days ago

     Winston-Salem’s public regenerative medicine company says it is still on schedule to resume...

10. • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 12 hours ago

      Longeveron (NASDAQ: LGVN), a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for life-threatening and chronic ...